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POTENT AND SELECTIVE INHIBITION OF HUMAN Ca2+-INDEPENDENT 
PHOSPHOLIPASE A2 BY FLUOROKETONES
Introduction
The superfamily of phospholipases A2 (PLA2) consists of hydrolytic enzymes that act
upon the sn-2 ester bond of phospholipids, releasing free fatty acids and lysophospholipids.
The main representative of these fatty acids is arachidonic acid, which can be transformed
into eicosanoids (prostaglandins, leukotriens, etc) by the action of other enzymes.
Lysophospholipids are precursors for other bioactive compounds, such as platelet-activating
factor (PAF). PAF and eicosanoids constitute basic mediators of inflammation. The three
predominant groups of phospholipase A2 found in human tissues are the cytosolic PLA2
(cPLA2), the calcium-independent PLA2 (iPLA2) and the secreted PLA2 (sPLA2). iPLA2 has
been proposed as a homeostatic enzyme involved in basal metabolism within the cell, but
has also been found to be involved in diseases of the brain, the heart and the central nervous
system, which makes this enzyme an attractive drug target. We have recently demonstrated
that Ca2+-independent phospholipase A2 (GVIA iPLA2) plays a key-role in experimental
autoimmune encephalomyelitis and that GVIA iPLA2 is a novel target for the development
of new therapies for multiple sclerosis.1
A series of fluoroketones has been presented as iPLA2 inhibitors and the structure-
activity relationship has been evaluated.2 To extend this research, we synthesized a variety
of polyfluoroketones containing an aromatic ring and a four carbon atom chain between the
ring and the polyfluoroketone group.
Synthesis
Commercially available aromatic aldehydes 1a-f were used as starting materials, to
prepare the desired fluoroketones (4a-f, 5a-f, 6a). Each aldehyde underwent a Horner –
Wadsworth – Emmons reaction with triethyl-4-phosphonocrotonate in the presence of LiOH
to produce the corresponding unsaturated ester 2a-f. After catalytic hydrogenation and
saponification with 1 N NaOH in ethanol we acquired the corresponding carboxylic acids
3a-f which were converted to acyl chlorides by the oxalyl chloride/DMF method. In situ,
acyl chlorides were treated with pyridine and trifluoroacetic anhydride or
pentafluoropropionic anhydride or heptafluorobutanoic anhydride to provide
trifluoromethyl ketones 4a-f, pentafluoroethyl ketones 5a-f and the heptafluoropropyl
ketone 6a, respectively (Scheme 1).
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Reagents and conditions: a) C2H5OOCCH=CHCH2P(=O)(OC2H5)2, LiOH, THF, 77
oC, b) i) H2,
10% Pd/C, EtOH, ii) NaOH 1N, EtOH, c) (COCl)2, DMF, CH2Cl2, d) pyridine, (CF3CO)2O, CH2Cl2,
0 oC to r.t., e) pyridine, (CF3CF2CO)2O, CH2Cl2, 0
oC to r.t., f) pyridine, (CF3CF2CF2CO)2O, CH2Cl2,
0 oC to r.t.
In vitro results
All synthesized compounds were tested for inhibition on human GVIA iPLA2,
GIVA cPLA2 and GV sPLA2. (Table 1) The percentage of inhibition for each enzyme
was determined at 0.091 mol fraction, and XI(50) values were measured for inhibitors
which showed more than 93% inhibition for an enzyme. When compared to the known
inhibitor FKGK18, changing the position of the carbon chain on the naphthalene ring,
leads to less potency, but higher selectivity. Increasing the number of fluorine atoms,
GK172 and GK173 become less potent inhibitors of iPLA2. When a methoxy group is
added to the naphthalene ring, inhibitors GK213 and GK214 lose selectivity towards
iPLA2. The biphenyl group instead of the naphthalene shows a similar inhibition for
both iPLA2 and cPLA2 (GK174, GK175). The insertion of a trifluoromethyl group on
the aromatic ring presented excellent potency (GK178 and GK189), but poor
selectivity. In the case of GK176 and GK188 the fluorine on the aromatic ring shows
both great potency and selectivity towards iPLA2. When the fluorine atom is replaced
by a methoxy group, compounds GK177 and GK187 are currently the most potent
and selective inhibitors for iPLA2. Inhibitors GK176, GK177, GK187 and GK188
can be used to study the role of GVIA iPLA2 in neurological disorders.
Table 1: Inhibition of PLA2 by fluoroketones
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Scheme 1: Synthesis of polyfluoroketones
No Structure iPLA2 cPLA2 sPLA2
% 
inhibition
XI(50) % 
inhibition
XI(50) % 
inhibition
FKGK11 99.4 0.0014 ±
0.0001
N.D. 28
FKGK18 99.9 0.0002 ±
0.0000
93.1 0.039 ±
0.001
36.8
GK171,
4a
98.7 0.0018 ±
0.0002
77.4 31.9
GK172,
5a
96.4 0.0034 ±
0.0002
64.0 29.4
GK173,
6a
76.7 60.4 57.8
GK174,
4e
97.9 0.0189 ±
0.0045
96.5 0.0074 
±
0.0003
40.5 
GK175,
5e
94.6 0.0134 ±
0.0017
72.6 38.3
GK176,
4b
98.5 0.0002 ±
0.0000
41.4 N.D.
GK177,
4d
99.8 0.0001 ±
0.0000
54.3 N.D.
GK178,
4c
99.9 0.0002 ±
0.0000
83.9 30.4
GK187,
5d
99.8 0.0001 ±
0.0000
12.9 32.8
GK188,
5b
98.2 0.0003 ±
0.0000
22.2 29.3
GK189,
5c
98.9 0.0003 ±
0.0001
62.5 36.9
GK213,
4f
92.6 85.5 41.7
GK214,
5f
92.5 54.7 63.1
N.D. signifies compounds with less than 25% inhibition (or no detectable inhibition).
